Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
about
Behavioral analyses of GHB: receptor mechanismsThe Impact of Gamma Hydroxybutyrate (GHB) Legal Restrictions on Patterns of Use: Results from an International SurveyHospital in the field: prehospital management of GHB intoxication by medical assistance teams.Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study.Effects of gamma-hydroxybutyric acid on spatial learning and memory in adolescent and adult female rats.Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.Acute cocaine-related health problems in patients presenting to an urban emergency department in Switzerland: a case series.Preliminary web-based measures development for GHB: expectancies, functions, and withdrawalTemporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective studyHigh-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.Gamma-hydroxybutyrate--a drug of abuse.Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention.Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups.Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008-2010.Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses.Risk factors of γ-hydroxybutyrate overdosing.Development of a fluorescent sensor for an illicit date rape drug--GBL.Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission.γ Hydroxybutyrate use: exploring the influence of outcome expectancies through memory modeling.Response to "A web-based study of γ hydroxybutyrate (GHB): patterns, experiences, and functions of use".Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB.The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion.
P2860
Q24645147-BC9E85A7-6DE2-4BC4-9402-0085FCE8E943Q28748888-4BE40A28-68BD-4A11-814D-A61A6E137313Q30419339-40127589-5309-43FF-9DD1-010CF28DAD85Q33575947-3E6BBD61-7C65-4AE2-9EB0-9C3D989FF720Q34080663-B2F7DCEC-B6F0-4480-A878-57792DEC89C3Q34243521-83BD5E28-A411-471E-836E-21596226D7AAQ34285013-11288056-B1BF-4593-9A4C-DEF2183713FDQ35130732-385C254C-1DC5-4DB1-9D8E-E70BB51B4F4DQ35747305-135609FD-8128-423D-90DC-92147778CFD3Q35800113-D34CF7B7-F769-4367-B6E3-99144F076BEDQ36481361-258376A7-7FD9-4648-94ED-29F6A3E9D944Q36566720-A4AF6658-0E20-43C3-A79E-CE7614E0501CQ36806659-3F9AFEB7-1661-45E3-AF50-0E94E8DD2974Q37224304-228C8EB1-FDFA-4463-A288-59B3A5853534Q37872702-62C35AA9-7181-4903-84B0-29807D76C089Q38040442-C84767B3-769C-483A-8F18-A0BA393110EEQ38166827-639B51E6-A500-43AD-B3FA-99F27180B681Q38232868-9962A4D6-91F1-45D2-8595-DF2B6EE11790Q40091993-C6D30E9D-803D-4941-AD61-17E14F22F3E3Q42183368-49C71BED-8E64-4E6E-A52C-4285AEA0513DQ43883628-47E954D1-79ED-4FD7-B4E2-1A155905E306Q44357470-BD67D654-9B85-4210-A118-7C88E3ED8155Q47792461-B18A0421-D16C-4A82-97AD-2661E698CB8CQ48154192-F759AE32-94BC-4F48-9CF4-FCD1CE772D6FQ48272698-DEB8836F-B79E-4B9D-8F1F-384E676346C9Q48675986-196EA264-A7AC-4316-8A42-DFAA4C8ACD8DQ55123620-17A2CA7B-C71F-49B4-8FC4-6C22B5078759
P2860
Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@en
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@nl
type
label
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@en
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@nl
prefLabel
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@en
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@nl
P2093
P1476
Clinical features of gamma-hyd ...... comitant drug and alcohol use.
@en
P2093
Hugo Kupferschmidt
Isabelle Kunz
Matthias E Liechti
Peter Greminger
Rudolf Speich
P304
P356
10.1016/J.DRUGALCDEP.2005.07.010
P577
2005-09-06T00:00:00Z